title: Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.
abstract: Patent ductus arteriosus (PDA) is a common congenital heart disease that results when the ductus arteriosus, a muscular artery, fails to remodel and close after birth. A syndromic form of this disorder, Char syndrome, is caused by mutation in TFAP2B, the gene encoding a neural crest-derived transcription factor. Established features of the syndrome are PDA, facial dysmorphology, and fifth-finger clinodactyly. Disease-causing mutations are missense and are proposed to be dominant negative. Because only a small number of families have been reported, there is limited information on the spectrum of mutations and resulting phenotypes. We report the characterization of two kindreds (K144 and K145) with Char syndrome containing 22 and 5 affected members, respectively. Genotyping revealed linkage to TFAP2B in both families. Sequencing of TFAP2B demonstrated mutations in both kindreds that were not found among control chromosomes. Both mutations altered highly conserved bases in introns required for normal splicing as demonstrated by biochemical studies in mammalian cells. The abnormal splicing results in mRNAs containing frameshift mutations that are expected to be degraded by nonsense-mediated mRNA decay, resulting in haploinsufficiency; even if produced, the protein in K144 would lack DNA binding and dimerization motifs and would likely result in haploinsufficiency. Examination of these two kindreds for phenotypes that segregate with TFAP2B mutations identified several phenotypes not previously linked to Char syndrome. These include parasomnia and dental and occipital-bone abnormalities. The striking sleep disorder in these kindreds implicates TFAP2B-dependent functions in the normal regulation of sleep.
authors.affiliation: Department of Medicine, Howard Hughes Medical Institute and Yale University School of Medicine, New Haven, CT 06510, USA.
authors.forename: Arya
authors.initials: A
authors.lastname: Mani
authors.forename: Jayaram
authors.initials: J
authors.lastname: Radhakrishnan
authors.forename: Anita
authors.initials: A
authors.lastname: Farhi
authors.forename: Khary S
authors.initials: KS
authors.lastname: Carew
authors.forename: Carole A
authors.initials: CA
authors.lastname: Warnes
authors.forename: Carol
authors.initials: C
authors.lastname: Nelson-Williams
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Day
authors.forename: Barbara
authors.initials: B
authors.lastname: Pober
authors.forename: Matthew W
authors.initials: MW
authors.lastname: State
authors.forename: Richard P
authors.initials: RP
authors.lastname: Lifton
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics; D000328:Adult; D001842:Bone and Bones / Q000002:abnormalities; D004268:DNA-Binding Proteins / Q000235:genetics*; D004374:Ductus Arteriosus, Patent / Q000235:genetics*; D005260:Female; D008040:Genetic Linkage; D006239:Haplotypes; D006801:Humans; D009154:Mutation; D012893:Sleep Wake Disorders / Q000235:genetics*; D014071:Tooth Abnormalities / Q000235:genetics; D050656:Transcription Factor AP-2; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; C493677:TFAP2B protein, human; D050656:Transcription Factor AP-2; D014157:Transcription Factors